Arrotex bolsters pharmacy offering

Following the merger of Apotex and Arrow, the combined Arrotex entity now has a considerable portfolio of respiratory medicines – including two new products Arrotex Pharmaceuticals has announced a strategic partnership with Boehringer Ingelheim for the exclusive Australian reseller rights to respiratory products Spiriva (tiotropium 18 micrograms powder for inhalation) and Spiriva HandiHaler, both used